About Cureus
About
Cureus
The Open Access medical journal for a new generation of doctors, researchers and patients.
We’re eliminating barriers to the generation and dissemination of medical knowledge.
The Cureus Difference
Based in San Francisco, California, Cureus is a Springer Nature journal leveraging the power of an online, crowdsourced community platform to share and promote published medical knowledge around the world.
Better research
Faster publication
Access for everyone
No paywalls
No red tape
Authors retain copyright
Join our rapidly growing audience to discuss articles with their authors, assign post-publication ratings, and browse peer-reviewed articles across more than 60 medical specialties. Sign up for your free Cureus account today and help us revolutionize how medical knowledge is published, shared and accessed.
Editors-in-Chief
John R. Adler Jr., M.D.
Founder, CEO, Editor-in-Chief
John R. Adler is the Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology (Emeritus) at Stanford University. Dr. Adler's scholarly interests center on translational research, especially the development of new minimally invasive surgical approaches to a wide variety of intra- and extra-cranial diseases.
Alexander Muacevic, M.D.
Co-Founder, Co-Editor-in-Chief
Alexander Muacevic is the medical director of the European Radiosurgery Center in Munich, Germany and a professor at the University of Munich Hospitals. Dr. Muacevic's main clinical and scientific interest is full body radiosurgery using advanced image-guided robotic technology.
Explore selected recently published articles
View Top ArticlesAbout the Journal
Cureus is an Open Access, multispecialty, online-only medical journal owned by Springer Nature Group. For information on journal leadership, please refer to our FAQ page. For information about the journal’s business model, please refer to the Policies and Procedures section of our Author Guide. The following stats are from the prior six months. Averages are displayed for monthly reads, submission to publication time, and accepted articles published for free.
3.4
MillionMonthly Reads
51%
Acceptance Rate
33
DaysSubmission to Publication Time
31%
Accepted Articles Published for Free
Cureus is a signatory of the Declaration on Research Assessment (DORA), which emphasizes continued improvement in how researchers and the outputs of scholarly research are evaluated. While we recognize that Journal Impact Factor has value to many, we instead focus on article-level metrics such as reads, downloads and citations. Cureus also encourages all readers to submit an SIQ (Scholarly Impact Quotient) score for each article. SIQ is our unique post-publication rating that assesses article importance and quality by embracing the collective intelligence of the Cureus community-at-large. Impact Factor, alongside other metrics such as turnaround time, downloads and social media mentions, can help to provide an overall assessment of journal quality and its research output in the community.
1.2
5-Year Journal Impact Factor
1.2
2-Year Journal Impact Factor
40
K+Total Citations
Accepted Medical Specialties
Cureus currently recognizes the following medical specialties. Don’t see your specialty listed? Contact us at [email protected].
U
U
U
Total Percentage of Article Reads by Country
Featuring a global community of readers, the Cureus Journal of Medical Science showcases the value of providing accessible medical knowledge to clinicians, researchers, caregivers and patients around the world.
